NATRILIX SR TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

natrilix sr tablet

servier laboratories south africa (pty) ltd - tablet - see ingredients - each tablet contains indapamide 1,5 mg

COVERSYL PLUS TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

coversyl plus tablet

servier laboratories south africa (pty) ltd - tablet - see ingredients - each tablet contains indapamide 1,25 mg perindopril 4,0 mg

PREXUM TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

prexum tablet

servier laboratories south africa (pty) ltd - tablet - see ingredients - each tablet contains perindopril 4,0 mg

COVERSYL 5 mg PLUS TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

coversyl 5 mg plus tablet

servier laboratories south africa (pty) ltd - tablet - see ingredients - each tablet contains indapamide 1,25 mg perindopril arginine 5,0 mg

BIOCOVERSYL PLUS 10/2,5 TABLET South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

biocoversyl plus 10/2,5 tablet

servier laboratories south africa (pty) ltd - tablet - see ingredients - each tablet contains indapamide 2,5 mg perindopril arginine 10,0 mg

ARDIX GLICLAZIDE 60 mg MR gliclazide 60 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

ardix gliclazide 60 mg mr gliclazide 60 mg tablet blister pack

servier laboratories (aust) pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: magnesium stearate; lactose monohydrate; colloidal anhydrous silica; maltodextrin; hypromellose - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg-120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.

DIAMICRON 60 mg MR gliclazide 60 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

diamicron 60 mg mr gliclazide 60 mg tablet blister pack

servier laboratories (aust) pty ltd - gliclazide, quantity: 60 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; maltodextrin; hypromellose; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg-120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.